Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular risks
Pharma
Lilly dives deep into Foundayo's cardio perks in T2D, obesity
The data represent the deepest look so far at Foundayo’s cardiovascular potential in patients with type 2 diabetes and obesity.
Fraiser Kansteiner
Oct 1, 2026 11:38am
ESC: Amgen CMO touts Repatha 'inflection' on mortality data
Sep 3, 2026 8:30am
In a big win for generics drugmakers, SCOTUS sides with Hikma
Jun 4, 2026 3:11pm
Lilly answers FDA's call for more Foundayo safety information
Apr 16, 2026 9:43am
Novo's Rybelsus gains FDA expansion to reduce risk of MACE
Oct 21, 2025 10:45am
Novo's oral GLP-1 Rybelsus cuts heart disease risks
Mar 31, 2025 11:30am
